RHE logo

RHE

Profile

Full Name

Regional Health Properties, Inc.

Ticker Symbol

RHE

Exchange

NYSE American

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

October 9, 2017

Indexes

Not included

Website

http://regionalhealthproperties.com

Employees

114

Key Details

Price

$2.00

Market cap

Last Dividend

$0.72

TTM Dividend yield

-

Annual revenue

$18.34M(+6.82% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.00
RHE price is $2.00

30-Day Relative Volume

0.30
RHE 30-day relative volume is 0.30

Price Performance

Price Most recent change

-
RHE price change on Apr 7, 2025 is unknown

Price YTD change

+27.88%
RHE price is up +27.88% since January 1st

Price 1-year change

-30.07%
RHE price is down -30.07% year-on-year

Price 3-year change

-36.51%
RHE price is down -36.51% over the past 3 years

Price Range

Price All-time high

$27.72
RHE price is currently -92.78% below its historical high of $27.72

Price 3-year low

$0.13
RHE price is currently +1438.46% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.76M
RHE market capitalization is $3.76 million

Market cap 3-year change

-33.34%
RHE market capitalization is down -33.34% over the past 3 years

Market cap All-time high

$32.90M
RHE market capitalization is currently -88.58% below its historical high of $32.90 million

Market cap sector rank

10.78%
RHE market capitalization is higher than 10.78% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.19%
RHE shares outstanding is up +2.19% year-on-year

Shares Outstanding 3-Year Change

+4.98%
RHE shares outstanding is up +4.98% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.13
RHE beta is 1.13

200-day SMA

$1.84
RHE price is currently +8.46% above its 200-day simple moving average

50-day SMA

$1.71
RHE price is currently +16.74% above its 50-day simple moving average

RSI

55.33
RHE 14-day relative strength index is 55.33

Volume

0.30
RHE 30-day relative volume is 0.30

ATR

$0.30
RHE average true range is $0.30

10-day Historical Volatility

189.20%
RHE 10-day historical volatility is 189.20%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.72
RHE last dividend was $0.72 per share, with an ex-dividend date of October 13, 2015

Next Dividend

-
RHE next dividend has not yet been announced

Dividend per share

Dividend per share

-
RHE annual dividend per share value is unknown

Dividend per share Sector Rank

-
RHE annual dividend per share is unknown

Dividend per share 1-Year Change

-
RHE annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
RHE annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
RHE annual dividend yield value is unknown

Dividend yield Sector Rank

-
RHE annual dividend yield is unknown

Other

Payout ratio

-
RHE annual payout ratio value is unknown

Dividends paid

-
RHE annual dividends paid value is unknown

Free cash flow

$1.41M
RHE annual free cash flow is $1.41 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$18.34M
RHE annual revenue is $18.34 million

Revenue Analysts estimate

-
RHE annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+6.82%
RHE annual revenue is up +6.82% year-on-year

Revenue Sector rank

33.18%
RHE annual revenue is higher than 33.18% of companies in Healthcare sector

EPS

EPS

-
RHE annual earnings per share value is unknown

EPS Analysts estimate

-
RHE annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-
RHE annual earnings per share 1-year change is unknown

EPS Sector rank

-
RHE annual earnings per share is unknown

Profit

Gross profit

$8.30M
RHE annual gross profit is $8.30 million

Gross margin

45.26%
RHE annual gross profit margin is 45.26%

Operating profit

$829.00K
RHE annual operating income is $829.00 thousand

Operating margin

4.52%
RHE annual operating profit margin is 4.52%

Net income

-$3.22M
RHE annual net profit is -$3.22 million

Net margin

-
RHE annual net profit margin value is unknown

Expenses

Total expenses

$17.51M
RHE annual total expenses is $17.51 million

Operating expenses

$7.47M
RHE annual total operating expenses is $7.47 million

Cost of goods sold

$10.04M
RHE annual cost of goods sold is $10.04 million

Selling, general & administrative expenses

$5.41M
RHE annual SGA is $5.41 million

Depreciation and amortization

$2.06M
RHE annual depreciation & amortization is $2.06 million

Interest expense

$2.71M
RHE annual interest expense is $2.71 million

Income tax

-
RHE annual income tax value is unknown

EBIT & EBITDA

EBIT

-$508.00K
RHE annual earnings before interest & taxes is -$508.00 thousand

EBITDA

$2.22M
RHE annual EBITDA is $2.22 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$60.47M
RHE annual total assets is $60.47 million

Non current assets

$40.40M
RHE annual long term assets is $40.40 million

Current assets

$20.06M
RHE annual total current assets is $20.06 million

Cash and cash equivalents

$582.00K
RHE annual cash & cash equivalents is $582.00 thousand

Accounts receivable

$5.89M
RHE annual accounts receivable is $5.89 million

Inventory

-
RHE annual inventory value is unknown

Liabilities

Total liabilities

$63.38M
RHE annual total liabilities is $63.38 million

Long term liabilities

$46.13M
RHE annual total long term liabilities is $46.13 million

Current liabilities

$17.26M
RHE annual total current liabilities is $17.26 million

Accounts payable

$3.69M
RHE annual accounts payable is $3.69 million

Debt

Total debt

$43.96M
RHE annual total debt is $43.96 million

Total debt 1-year change

-18.07%
RHE annual total debt is down -18.07% year-on-year

Long term debt

$43.46M
RHE annual long term debt is $43.46 million

Short term debt

-
RHE annual short term debt value is unknown

Equity & Capital

Shareholders equity

-$2.92M
RHE annual stockholders equity is -$2.92 million

Book value

-$26.07M
RHE annual book value is -$26.07 million

Retained earnings

-$85.12M
RHE annual retained earnings is -$85.12 million

Working capital

$2.81M
RHE annual working capital is $2.81 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.94M
RHE annual cash flow from operations is $1.94 million

Cash from operations 1-year change

-47.66%
RHE annual cash flow from operations is down -47.66% year-on-year

Cash from investing

-$530.00K
RHE annual cash flow from investing activities is -$530.00 thousand

Cash from investing 1-year change

+44.68%
RHE annual cash flow from investing activities is up +44.68% year-on-year

Cash from financing

-$2.13M
RHE annual cash flow from financing activities is -$2.13 million

Cash from financing 1-year change

+14.28%
RHE annual cash flow from financing activities is up +14.28% year-on-year

CAPEX

CAPEX

$530.00K
RHE annual capital expenditures is $530.00 thousand

CAPEX 1-year change

-44.68%
RHE annual capital expenditures is down -44.68% year-on-year

Free Cash Flow

Free cash flow

$1.41M
RHE annual free cash flow is $1.41 million

Free cash flow 1-year change

-48.69%
RHE annual free cash flow is down -48.69% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

45.26%
RHE annual gross profit margin is 45.26%

Operating margin

4.52%
RHE annual operating profit margin is 4.52%

Net margin

-
RHE annual net profit margin value is unknown

ROA & ROE

ROA

-5.32%
RHE annual return on assets is -5.32%

ROE

110.24%
RHE annual return on equity is 110.24%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RHE price to earnings ratio value is unknown

PE ratio Sector rank

-
RHE price to earnings ratio is unknown

PB Ratio

PB ratio

-0.14
RHE price to book ratio is -0.14

PB ratio Sector rank

12.7%
RHE price to book ratio is higher than 12.7% of companies in Healthcare sector

PS Ratio

PS ratio

0.20
RHE price to sales ratio is 0.20

PS ratio Sector rank

7.45%
RHE price to sales ratio is higher than 7.45% of companies in Healthcare sector

Enterprise value

Enterprise value

$47.14M
RHE enterprise value is $47.14 million

Enterprise value Sector rank

40.41%
RHE enterprise value is higher than 40.41% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

30.35
RHE EV/EBITDA is 30.35

EV/EBITDA Sector rank

94.95%
RHE EV/EBITDA is higher than 94.95% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.16
RHE annual current ratio is 1.16

Quick ratio

-
RHE annual quick ratio value is unknown

Leverage

Debt to equity

-15.06
RHE annual debt to equity ratio is -15.06

Interest coverage ratio

-0.19
RHE annual interest coverage ratio is -0.19

Risk & Stability

Piotroski F-Score

5
RHE piotroski f-score is 5

Altman Z-Score

-1.60
RHE altman z-score is -1.60

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

XBIO logo
Xenetic Biosciences (XBIO)
ATIP logo
ATI Physical Therapy (ATIP)
KTTA logo
Pasithea Therapeutics (KTTA)
TOVX logo
Theriva Biologics (TOVX)
SNOA logo
Sonoma Pharmaceuticals (SNOA)
GENE logo
Genetic Technologies Limited (GENE)
MBIO logo
Mustang Bio (MBIO)
SONN logo
Sonnet BioTherapeutics Holdings (SONN)
PRFX logo
PainReform (PRFX)
  • What is the ticker symbol for Regional Health Properties?
  • Does Regional Health Properties pay dividends?
  • What sector is Regional Health Properties in?
  • What industry is Regional Health Properties in?
  • What country is Regional Health Properties based in?
  • When did Regional Health Properties go public?
  • Is Regional Health Properties in the S&P 500?
  • Is Regional Health Properties in the NASDAQ 100?
  • Is Regional Health Properties in the Dow Jones?
  • When was Regional Health Properties's last earnings report?
  • When does Regional Health Properties report earnings?

What is the ticker symbol for Regional Health Properties?

The ticker symbol for Regional Health Properties is NYSE American:RHE

Does Regional Health Properties pay dividends?

No, Regional Health Properties does not pay dividends

What sector is Regional Health Properties in?

Regional Health Properties is in the Healthcare sector

What industry is Regional Health Properties in?

Regional Health Properties is in the Medical Care Facilities industry

What country is Regional Health Properties based in?

Regional Health Properties is headquartered in United States

When did Regional Health Properties go public?

Regional Health Properties's initial public offering (IPO) was on October 9, 2017

Is Regional Health Properties in the S&P 500?

No, Regional Health Properties is not included in the S&P 500 index

Is Regional Health Properties in the NASDAQ 100?

No, Regional Health Properties is not included in the NASDAQ 100 index

Is Regional Health Properties in the Dow Jones?

No, Regional Health Properties is not included in the Dow Jones index

When was Regional Health Properties's last earnings report?

Regional Health Properties's most recent earnings report was on Mar 23, 2018

When does Regional Health Properties report earnings?

The date for Regional Health Properties's next earnings report has not been announced yet
On this page